Verastem (VSTM) Shareholder's Equity Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.44% |
| Dec 31, 2025 | -13.08% |
| Sep 30, 2025 | -16.21% |
| Jun 30, 2025 | -20.62% |
| Mar 31, 2025 | -17.75% |
| Dec 31, 2024 | -43.23% |
| Sep 30, 2024 | -12.46% |
| Jun 30, 2024 | -17.49% |
| Mar 31, 2024 | -22.29% |
| Dec 31, 2023 | -14.33% |
| Sep 30, 2023 | -5.02% |
| Jun 30, 2023 | -4.35% |
| Mar 31, 2023 | -3.05% |
| Dec 31, 2022 | -3.85% |
| Sep 30, 2022 | 8.94% |
| Jun 30, 2022 | 2.24% |
| Mar 31, 2022 | 3.77% |
| Dec 31, 2021 | 3.90% |
| Sep 30, 2021 | 3.02% |
| Jun 30, 2021 | -0.19% |
| Mar 31, 2021 | 1.35% |
| Dec 31, 2020 | 2.38% |
| Sep 30, 2020 | 2.94% |
| Jun 30, 2020 | -1.80% |
| Mar 31, 2020 | -1.39% |
| Dec 31, 2019 | -39.54% |
| Sep 30, 2019 | -24.69% |
| Jun 30, 2019 | -13.04% |
| Mar 31, 2019 | -4.15% |
| Dec 31, 2018 | 1.14% |
| Sep 30, 2018 | -3.21% |
| Jun 30, 2018 | 11.18% |
| Mar 31, 2018 | -14.18% |
| Dec 31, 2017 | -8.61% |
| Sep 30, 2017 | -15.58% |
| Jun 30, 2017 | -13.97% |
| Mar 31, 2017 | -10.90% |
| Dec 31, 2016 | 50.27% |